Protease

News

Related Video News

No related video news stories found.

Organic Broadcast Project

Related Videos

No related videos found.

Activist Investor Pushes Celera to Divest Merck Bone Drug Royalties

Published February 9, 2010, 6:05 pm, BioWorld

The Biotechnology Value Fund (BVF), a historically activist investor group, revealed in a 13-D filing Tuesday the reason for its recent interest in diagnostics firm Celera Corp.: BVF wants Celera to spin out its royalty interest in Merck & Co. Inc.'s Phase III osteoporosis drug, odanacatib.

Discover News | Full Story


Gilead's quad pill for AIDS patients may overtake Atripla, COO says

Published February 9, 2010, 4:49 pm, San Jose Mercury News

Gilead Sciences, the world's biggest maker of AIDS medicines, will begin three final-stage tests this year for a four-drug combination pill against HIV that has the potential to generate $4 billion a year by 2014.

Discover News | Full Story


Gilead Quad Pill May Overtake Atripla, Milligan Says (Update2)

Published February 9, 2010, 1:36 pm, Bloomberg

Feb. 9 (Bloomberg) -- Gilead Sciences Inc ., the world’s biggest maker of AIDS medicines, will begin three final-stage tests in 2010 for a four-drug combination pill against HIV that has the potential to generate $4 billion a year.

Discover News | Full Story


Ambrilia Biopharma Provides Bi-Weekly Status Update

Published February 8, 2010, 9:28 am, Marketwire

MONTREAL, QUEBEC--(Marketwire - Feb. 8, 2010) - A

Discover News | Full Story


Ambrilia Biopharma Provides Bi-Weekly Status Update

Published February 8, 2010, 9:17 am, Marketwire via Yahoo! Finance

MONTREAL, QUEBEC--(Marketwire - 02/08/10) - ATTENTION BUSINESS/FINANCIAL/HEALTH EDITORS Ambrilia Biopharma Inc. (TSX: AMB - News ) is providing today its bi-weekly Default Status Report under National Policy 12-203 - Cease Trade Orders for Continuous Disclosure Defaults ("Default Status Report"). On November 16, 2009, Ambrilia announced that the filing of its interim financial statements ...

Discover News | Full Story


YOU ARE HERE:

Published February 8, 2010, 5:46 am, Aidsmap

Amongst patients experiencing a rebound in viral load, those taking 3TC (lamivudine, Epivir ) in combination with tenofovir ( Viread ) were more likely than those taking FTC (emtricitabine, Emtriva ) and tenofovir to develop a number of key resistance mutations.

Discover News | Full Story


Mimotopes Awarded Major Peptide Supply Contract by the Queensland Institute of Medical Research in the Search for an ...

Published February 8, 2010, 12:08 am, PRWeb

Mimotopes' PepSets™ to be used to identify novel proteins from the malaria parasite for next generation vaccine development (PRWeb Feb 8, 2010) Read the full story at http://www.prweb.com/releases/2010/02/prweb3564994.htm

Discover News | Full Story


Mimotopes Awarded Major Peptide Supply Contract by the Queensland Institute of Medical Research in the Search for an ...

Published February 7, 2010, 11:01 pm, PRWeb via Yahoo! News

Mimotopes' PepSets™ to be used to identify novel proteins from the malaria parasite for next generation vaccine development

Discover News | Full Story


Novel Therapies Could Improve Potency Of Existing AIDS Treatments, Help To Combat Drug-Resistant Virus Strains

Published February 5, 2010, 3:34 am, Medical News Today

A team of scientists at The Scripps Research Institute has identified two compounds that act on novel binding sites for an enzyme used by the human immunodeficiency virus (HIV), the virus that causes AIDS. The discovery lays the foundation for the development of a new class of anti-HIV drugs to enhance existing therapies, treat drug-resistant strains of the disease, and slow the evolution of ...

Discover News | Full Story


US scientists find ideal target for malaria therapy

Published February 4, 2010, 7:24 pm, People's Daily

Scientists at Washington University School of Medicine in St. Louis have identified a protein made by the malaria parasite that is essential to its ability to take over human red blood cells, the university said Wednesday in a statement. Malaria, which is spread by mosquito bites, kills between one million and three million people annually in developing countries. Death results from damage to ...

Discover News | Full Story



News Directory

Get started fast by using a pre-defined news directory category

Breaking News
and Top Stories
Business
Earnings, Economy, Personal Finance, and Stock Markets
Entertainment
Books, Celebrity, Fashion, Movies, Music, Television, and Theatre
Health
Aging, Diseases, Medical Conditions, Medications, Sexual Health, and Weight Loss
Politics
Congress, Supreme Court, and White House
Science
Animals, Astronomy, Biotechnology, Space, and Weather
Sports
Baseball, Basketball, Boxing, Football, Golf, Hockey, Motor Sports, Soccer, and Tennis
Technology
Communications, Hardware, Internet, Personal Technology, and Software
United States
and Crimes and Trials
World
Africa, Antartica, Asia, Australia, Canada, Europe, Latin America, and Middle East


© Copyright 2005-2006 News Meme, All Rights Reserved | More News | Link Index | OSWD Design

Powered by Odin Assemble 2.5a